MacroGenics Inc at Citi Immuno-Oncology Summit (Virtual) Transcript
Okay. Great. Well, welcome back, everyone, to Citi's 2022 Immuno-Oncology Summit. I'm Yigal Nochomovitz. I'm one of the biotech analysts here at Citi. Most of you know who I am. As a reminder, if you'd like to ask questions during the session with MacroGenics, then just e-mail me, [email protected]. Most of you should have my e-mail address in your inbox. And I can relay the questions to Scott.
So with that, I'd like to welcome Scott Koenig, CEO of MacroGenics. And we also have Jim Karrels, CFO, in the background to answer any financial-related questions.
Questions & Answers
So Scott, maybe just to start out the session. It would be great if you could just give us a high-level summary of MacroGenics' corporate strategy? What is the near-term mission of the company? What is the longer-term mission? Just to help those investors that are less familiar.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
